Role of nitric oxide in D-galactosamine-induced cell death and its protection by PGE1 in cultured hepatocytes

Nitric Oxide. 2003 Mar;8(2):133-43. doi: 10.1016/s1089-8603(02)00182-9.

Abstract

Prostaglandin E(1) (PGE(1)) reduces cell death in experimental and clinical manifestations of liver dysfunction. Nitric oxide (NO) has been shown to exert a protective or noxious effect in different experimental models of liver injury. The aim of the present study was to investigate the role of NO during PGE(1) protection against D-galactosamine (D-GalN) citotoxicity in cultured hepatocytes. PGE(1) was preadministered to D-GalN-treated hepatocytes. The role of NO in our system was assessed by iNOS inhibition and a NO donor. Different parameters related to apoptosis and necrosis, NO production such as nitrite+nitrate (NO(x)) release, iNOS expression, and NF-kappaB activation in hepatocytes were evaluated. The inhibition of iNOS reduced apoptosis induced by D-GalN in hepatocytes. PGE(1) protection against D-GalN injury was associated with its capacity to reduce iNOS expression and NO production induced by D-GalN. Nevertheless, iNOS inhibition showed that protection by PGE(1) was also mediated by NO. Low concentrations of a NO donor reduced D-GalN injury with a decrease in the extracellular NO(x) concentration. High concentrations of the NO donor enhanced NO(x) concentration and increased cell death by D-GalN. The present study suggests that low NO production induced by PGE(1) preadministration reduces D-GalN-induced cell death through its capacity to reduce iNOS expression and NO production caused by the hepatotoxin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins
  • Blotting, Western
  • Caspase 3
  • Caspases / analysis
  • Caspases / biosynthesis
  • Cell Death / drug effects*
  • Cells, Cultured
  • Data Interpretation, Statistical
  • Electrophoretic Mobility Shift Assay
  • Galactosamine / antagonists & inhibitors
  • Hepatocytes / drug effects*
  • Hepatocytes / pathology
  • L-Lactate Dehydrogenase / analysis
  • L-Lactate Dehydrogenase / drug effects
  • Male
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / biosynthesis
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase Type II
  • Penicillamine / analogs & derivatives*
  • Penicillamine / pharmacology
  • Prostaglandins E / metabolism
  • Prostaglandins E / pharmacology*
  • Proteins / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • Apoptosis Regulatory Proteins
  • DAP protein, human
  • NF-kappa B
  • Nitric Oxide Donors
  • Prostaglandins E
  • Proteins
  • S-nitro-N-acetylpenicillamine
  • Nitric Oxide
  • Galactosamine
  • L-Lactate Dehydrogenase
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • CASP3 protein, human
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • Penicillamine